John C. Peters

John C. Peters has an extensive background in pharmaceutical and medical sales, with significant experience across various therapeutic areas. From May 2011 to September 2015, John worked as a Therapeutic Specialist at Gilead Sciences, focusing on cardiovascular products and managing key accounts in New York. John then held a Key Account Manager position at Amgen, where responsibilities included implementing POST-MI protocols at multiple NYC hospitals. Subsequent roles included Senior BioPharmaceutical Sales Representative for cardiology and Senior Neurology Account Specialist at Eisai US, overseeing the LEQEMBI launch for Alzheimer's disease. Prior to these, John served as Partnerships Manager at Alto Pharmacy and held positions at GSK and Cintas. John is currently a Therapeutic Specialist in Rare Disease at BridgeBio, continuing to leverage expertise in marketing gained from a Bachelor of Applied Science in Marketing from Le Moyne College.